Presentations
2
Abstracts
3
Advisory boards
0
Planned
14
Actual
—
Not yet recorded
| ID | Title | Type | Status | Owner |
|---|---|---|---|---|
| PUB-0002 | Real-world treatment patterns after progression on first-line vantrelimab: study design of SEQUENCE-RW | Abstract | Accepted | David Chen |
| PUB-0004 | Efficacy of vantrelimab in patients ≥ 75 years: VOYAGE-1 subgroup analysis | Poster | Accepted | David Chen |
0 completed of 24 planned · congress meetings recorded 14 Oct 2026 – 22 Oct 2026
No congress-meeting engagements recorded in the event window
Count on record: 0
No insights link to this congress as source record
0 of 0 completed
Budget
$510k
Spend to date
$198k
39% consumed
Variance
−$312k
Under budget
Event not yet started; performance is assessed after completion.
RAG derived from the lowest of engagement, follow-up and attendance completion ratios (Green ≥ 90%, Amber ≥ 60%); budget overrun caps at Amber.
No audit events for this record
Create, update, approve and export events appear here with user, timestamp, previous and new values.